21 CFR Part 11 Compliance

FDA 21 CFR Part 11 compliance assessment and remediation services for pharmaceutical GxP systems. The engagement covers the Part 11 gap analysis, the remediation roadmap, and the implementation support.

Part 11 requirements

21 CFR Part 11 covers electronic records and electronic signatures for FDA-regulated manufacturers. Key requirements include unique user IDs, controlled electronic signatures, closed system audit trails, authority checks, record integrity, and validation documentation.

Part 11 gap analysis

A Part 11 gap analysis reviews the GxP systems against the Part 11 requirements. The analysis identifies gaps, classifies them by risk, and prioritizes them for remediation.

Remediation roadmap

The remediation roadmap defines the corrective actions, the system configuration changes, the procedural changes, and the validation activities required to close the gaps.

Audit trail implementation

A key Part 11 requirement is the closed system audit trail. The practice helps clients design the audit trail, configure the system, validate the audit trail, and establish the audit trail review routine.

How to use this page

Use this 21 CFR Part 11 Compliance page as a planning checkpoint before vendor selection, architecture review, validation scoping or implementation sequencing. The strongest next step is to compare the guidance with your current SOPs, system inventory, batch records, data flows and QA review routines so the discussion starts from evidence instead of assumptions.

Evidence to prepare

For 21 CFR Part 11 Compliance, prepare the records, owners, risks and decision criteria linked to part 11 requirements, part 11 gap analysis, remediation roadmap, audit trail implementation. Useful evidence includes current process maps, interface lists, audit trail expectations, exception workflows, data retention rules and the business reason for changing the current operating model.

Frequently asked questions

Is Part 11 applicable to all GxP systems?

Part 11 applies to electronic records and electronic signatures used in FDA-regulated manufacturing.

What is the relationship between Part 11 and Annex 11?

Part 11 (FDA) and Annex 11 (EU) cover similar requirements with subtle differences. Most manufacturers need to comply with both.